Position:
Clinical Fellow in Hematology and Oncology at Emory University, Co-Chief Fellow at Post Graduate Training, Fellow in Hematolgy and Oncology at Emory University School of Medicine
Work:
Emory University
since Jul 2007
-
Clinical Fellow in Hematology and Oncology
Post Graduate Training
since Jan 2007
-
Co-Chief Fellow
Emory University School of Medicine
since Jul 2006
-
Fellow in Hematolgy and Oncology
Johns Hopkins Bayview Hospital Bayview Medical Center
Jan 2003 - Jan 2006
-
Resident in Internal Medicine
Education:
M.D. Anderson Cancer Center 1996 - 2001
Studied the significance of Serine 354 within the BCR ser/thr kinase domain for in vitro phosphorylation, ABL-SH2 binding, and inhibition of growth of Bcr-Abl - positive cells
Mentor: Ralph B. Arlinghaus, Ph.D.
Professor and Chairman of the Department
Brown University
Ph.D Associate Professor, BiochemistryStudied the effects of the Protein Kinase C Inhibitor, Chelerythrine, on the rate of degradation of the Bcr-Abl protein in CML cells**
Mentor: A. R. Frackelton, PhD
Department of Medicine Roger Williams Hospital and Brown University
** Presented poster and abstract at the 1995 American
Association of Cancer Research (AACR)
Department of Medicine, Roger Williams Hospital, Brown University
Program; Department; M. D, Pathobiology; Molecular Pathology
Emory University School of Medicine
Mentor: Fadlo Khuri, M.D.
Professor and Chair of Departments of Hematology and
Oncology
Graduate Studies: Brown University
PhD; PhD, PathobiologyReceived MD: May, 2003
Received PhD: May, 2007
Spelman College
Spelman College
B. S, Natural Sciences
University of Texas at Houston
M. D; Ph.D. Associate Professor, Anderson Cancer Center; Biochemistry
Visiting Student at Brown University
Research Training
2006-07 Studied interactions between mTOR and MAP Kinase
Pathways in Non small cell lung cancer cell lines.
Mentor: Shi-Yong Sun, PhD
Associate Professor
Skills:
mentoring, clinical research with close collaboration with basic scientists for potential Phase I or Phase II trial development with novel, promising drugs or small molecules